[NBIX] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
09-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 29.93%
YoY- 1,319.18%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 498,800 452,700 420,400 412,000 387,900 378,200 310,600 37.09%
PBT 115,600 121,600 -103,300 117,900 97,900 -23,300 21,400 207.55%
Tax 32,500 26,100 -26,700 28,900 29,400 -6,400 7,500 165.55%
NP 83,100 95,500 -76,600 89,000 68,500 -16,900 13,900 229.04%
Tax Rate -28.11% -21.46% - -24.51% -30.03% - -35.05% -
Total Cost 415,700 357,200 497,000 323,000 319,400 395,100 296,700 25.18%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 16.66 21.10 -18.22 21.60 17.66 -4.47 4.48 139.83%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS 0.85 0.98 -0.79 0.92 0.72 -0.18 0.15 217.51%
EPS Diluted 0.82 0.95 -0.79 0.88 0.69 -0.18 0.14 224.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.